GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GRAIL Inc (MEX:GRAL) » Definitions » YoY EBITDA Growth

GRAIL (MEX:GRAL) YoY EBITDA Growth : 31.95% (As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is GRAIL YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. GRAIL's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was 31.95%.

GRAIL's EBITDA per Share for the three months ended in Mar. 2025 was MXN-68.18.

GRAIL YoY EBITDA Growth Historical Data

The historical data trend for GRAIL's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GRAIL YoY EBITDA Growth Chart

GRAIL Annual Data
Trend Dec18 Dec19 Dec22 Dec23 Dec24
YoY EBITDA Growth
- 13.80 -147.61 5.45 -14.33

GRAIL Quarterly Data
Dec18 Dec19 Jun20 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.10 -17.03 -3.06 28.49 31.95

GRAIL YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

GRAIL's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(-398.904--348.909)/ | -348.909 |
=-14.33 %

GRAIL's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY EBITDA Growth (Q: Mar. 2025 )
=(EBITDA per Share (Q: Mar. 2025 )-EBITDA per Share (Q: Mar. 2024 )) / | EBITDA per Share (Q: Mar. 2024 )) |
=(-68.175--100.182)/ | -100.182 |
=31.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GRAIL YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of GRAIL's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

GRAIL Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GRAIL Inc (MEX:GRAL) » Definitions » YoY EBITDA Growth
Comparable Companies
NEO NEOG OPK CDNA MYGN CSTL FLGT PSNL STIM ATLN TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD NTRA WAT
Traded in Other Exchanges
GRAL:USA NL0:Germany NL0:Germany
Address
1525 O’Brien Drive, Menlo Park, CA, USA, 94025
Website
https://www.grail.com
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.